Speaker Profile

MD, PhD, Chief Medical Officer, Hedera Dx

Dr. Christian Meisel, MD PhD, is a highly accomplished physician scientist with substantial contributions to the field of medicine and innovation in drug development. He holds board certifications in Internal Medicine and Clinical Pharmacology from the Charité University Hospital and has an additional background in Informatics. Dr. Meisel is renowned as a thought leader in Precision Oncology, where he played a central role in advancing drug development and clinical diagnostics. Prior to co-founding Hedera Dx and assuming the role of Chief Medical Officer, Dr. Meisel had a distinguished career in the biopharmaceutical industry. He held key global leadership positions at Roche, including Global Head Translational Medicine Oncology, Oncology Biomarkers, and Personalized Healthcare Platforms. Additionally, his role as Chief Medical Officer at Molecular Health exemplified his leadership and expertise in patient-centric precision medicine and clinical decision support.

Hedera Dx: Transforming Oncology Through Liquid Biopsy
Liquid Biopsy has the potential to transform Oncology. Hedera Dx pioneers noninvasive liquid biopsy solutions, reshaping oncology and significantly enhancing patient outcomes through better diagnostics for more patients as well as by accelerating and improving drug development through patient-centricity and clinicogenomics realworld evidence generation.

Clinical Dx Showcase:
Hedera Dx

Hedera Dx is on a mission to improve patient outcomes by simplifying clinical cancer testing and providing an unprecedented platform for cancer drug development

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.30 A.M.-1.45 P.M.,Showcase Track S2 - January 25 9.00 A.M.-4.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-2.45 P.M.

The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required